Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature

BACKGROUND: The randomized trial PRODIGE 7 failed to show the benefit of oxaliplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal peritoneal metastasis treatment (CR PM). This systematic review focuses on the association of cisplatin (CDDP) with mitomycin C (MMC) in HIPEC in CR PM...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Amandine, Pocard, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668656/
https://www.ncbi.nlm.nih.gov/pubmed/31388562
http://dx.doi.org/10.1515/pp-2019-0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668656/
https://www.ncbi.nlm.nih.gov/pubmed/31388562
http://dx.doi.org/10.1515/pp-2019-0006

Ejemplares similares